Sandgaard Capital

Thomas Sandgaard, CEO of Sandgaard Capital, shares his perspective on the state of the economy in 2025 — where resilience meets uncertainty, and opportunity emerges.

Read his full insights here: https://www.sandgaardcapital.com/executiveinsights/the-state-of-the-economy-perspective-from-sandgaard-capital

The State of the Economy: Perspective — Sandgaard Capital By: Thomas Sandgaard, CEO of Sandgaard Capital

📢 Leadership Update at Zynex Inc (NASDAQ: ZYXI)

We’re excited to share that Steven Dyson has officially taken the helm as CEO of Zynex, joined by a strengthened executive team:

- Vikram Bajaj – Chief Financial Officer (finance & strategy leader with 20+ years in medtech)

- John T. Bibb – Chief Legal Officer (legal, HR & compliance expertise across major healthcare firms)

- Ajay Gopal – EVP of Sales (track record of commercial growth and expanding patient access)

- Agnes Powell – VP of Billing (20 years of experience in revenue cycle and managed care operations)

Board Chairman Thomas Sandgaard expressed confidence in this proven group of leaders to “take Zynex to new levels of success.”

CEO Steven Dyson added: “We have the right team in place to deliver excellent results while renewing our commitment to integrity and improving quality of life for patients suffering from pain and illness.”

📈 Zynex shares rose nearly 6% following the announcement.

At Sandgaard Capital, we remain committed to supporting Zynex as it enters this next phase of growth and transformation.

Click here to learn more: https://www.proactiveinvestors.com/companies/news/1076873/zynex-beefs-up-executive-team-as-new-ceo-dyson-takes-helm-1076873.html

$ZYXI

🚨 Zynex (NASDAQ: ZYXI) Secures UK Patent for Non-Invasive Sepsis Monitoring Technology 🚨

Zynex Monitoring Solutions has been awarded a UK patent for its groundbreaking multiparameter, non-invasive sepsis monitor — a device designed to help clinicians detect sepsis earlier by continuously tracking multiple vital signs.

🦠 Sepsis affects over 1.7 million people annually in the U.S. and is responsible for 1 in 3 hospital deaths.

📊 Early detection remains one of the biggest challenges in treating this life-threatening condition.

🌍 Zynex’s technology supports global efforts like the Surviving Sepsis Campaign to reduce sepsis-related mortality.

CEO Thomas Sandgaard stated:
“Sepsis is a global health crisis. This technology has the potential to drastically reduce deaths by delivering real-time, non-invasive data to clinicians.”

Donald Gregg, President of Zynex Monitoring Solutions, added:
“We believe we can significantly contribute to earlier detection and better outcomes.”

Zynex continues to lead innovation in critical care monitoring with a focus on improving patient lives.

Read more here: https://www.proactiveinvestors.com/companies/news/1073616/zynex-awarded-uk-patent-for-non-invasive-sepsis-monitoring-technology-1073616.html

Zynex Expands Medical Innovation Portfolio! ✨

Zynex Inc. (Nasdaq: ZYXI) is breaking barriers with its cutting-edge NiCO laser pulse oximeter, designed for unparalleled precision in measuring blood oxygen levels.

Following successful trials at Duke University, the device addresses inaccuracies in traditional oximeters, particularly for individuals with darker skin tones, paving the way for equitable healthcare solutions.

The company eyes FDA submission by June and continues its mission to revolutionize pain management with products like the NexWave and TensWave devices.

✨Big news: Zynex recently partnered with Veterans Affairs Medical Centers, opening doors to serve over 9 million veterans with advanced, non-opioid pain management solutions.

Stay tuned for updates as Zynex shapes the future of healthcare!

Read the entire article via the following link to learn more: https://www.proactiveinvestors.com/companies/news/1065206/zynex-eyes-fda-submission-for-nico-oximeter-as-it-expands-portfolio-of-innovative-medical-devices-1065206.html

Zynex Medical Zynex Monitoring Solutions Thomas Sandgaard |

Zynex eyes FDA submission for NiCO oximeter as it expands portfolio of innovative medical devices Zynex Inc (NASDAQ:ZYXI) continues to expand its portfolio of innovative, non-invasive medical devices targeting pain management, rehabilitation, and pain...